Literature DB >> 9851952

Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging.

S R Kapadia1, S E Nissen, K M Ziada, V Guetta, T D Crowe, R E Hobbs, R C Starling, J B Young, E M Tuzcu.   

Abstract

BACKGROUND: Transplant coronary artery disease is a combination of atherosclerosis transmitted from the donor and new lesions of allograft vasculopathy. We sought to determine the morphological characteristics of allograft vasculopathy and differentiate it from donor-transmitted atherosclerosis with serial intravascular ultrasound. METHODS AND
RESULTS: Intravascular ultrasound examination was performed in 93 patients at 27.2+/-15.0 and 369. 7+/-23.9 days after transplantation. The maximally and minimally diseased sites were selected in each segment as defined by Coronary Artery Surgery Study classification. For each matched site, maximal plaque thickness was measured. Lesions (maximum plaque thickness >/=0.5 mm) present at baseline examination were defined as donor lesions. On follow-up, lesions that developed at previously normal sites were defined as de novo lesions. The distribution and severity of donor and de novo lesions were similar in proximal, mid, and distal segments. The de novo lesions were less focal (43% vs 74%) and more circumferential (69% vs 45%) compared with the donor lesions, but there was significant morphological heterogeneity. Similar numbers of patients with and those without donor lesions developed de novo lesions. Moreover, progression of donor lesions was not associated with the presence or absence of de novo lesions.
CONCLUSIONS: Differentiation between early allograft vasculopathy from conventional atherosclerosis by distribution and morphology of lesions alone is difficult. Serial intravascular ultrasound imaging with early baseline examination is necessary to make this distinction. This distinction is important because the progression of donor lesions and the development of de novo lesions are independent of each other.

Entities:  

Mesh:

Year:  1998        PMID: 9851952     DOI: 10.1161/01.cir.98.24.2672

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors.

Authors:  K Pethig; V Klauss; B Heublein; H Mudra; A Westphal; C Weber; K Theisen; A Haverich
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 2.  Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation.

Authors:  Amandeep Dhaliwal; Vinay Thohan
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

Review 3.  Recent trends in coronary intravascular ultrasound: tracking atherosclerosis, pursuit of vulnerable plaques, and beyond.

Authors:  Ilke Sipahi; Stephen J Nicholls; E Murat Tuzcu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

4.  Reduced progression of cardiac allograft vasculopathy with routine use of induction therapy with basiliximab.

Authors:  Ricardo Wang; Lidia Ana Zytynski Moura; Sergio Veiga Lopes; Francisco Diniz Affonso da Costa; Newton Fernando Stadler Souza Filho; Tiago Luiz Fernandes; Natália Boing Salvatti; José Rocha Faria-Neto
Journal:  Arq Bras Cardiol       Date:  2015-06-23       Impact factor: 2.000

5.  Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis.

Authors:  Takuya Watanabe; Osamu Seguchi; Masanobu Yanase; Tomoyuki Fujita; Yoshihiro Murata; Takuma Sato; Haruki Sunami; Seiko Nakajima; Yu Kataoka; Kunihiro Nishimura; Eriko Hisamatsu; Kensuke Kuroda; Norihiro Okada; Yumiko Hori; Kyoichi Wada; Hiroki Hata; Hatsue Ishibashi-Ueda; Yoshihiro Miyamoto; Norihide Fukushima; Junjiro Kobayashi; Takeshi Nakatani
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

Review 6.  Management of the ACC/AHA Stage D patient: cardiac transplantation.

Authors:  Michelle M Kittleson; Jon A Kobashigawa
Journal:  Cardiol Clin       Date:  2013-10-23       Impact factor: 2.213

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.